# Why Patients Decline or Are Being Deemed Ineligible to Receive Home-based Treatment: a Mixed Methods Study

> **NCT07634263** · — · NOT_YET_RECRUITING · sponsor: **Odense University Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma
- Multiple Myeloma Progression
- Multiple Myeloma Refractory

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07634263
- **Lead sponsor:** Odense University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2027-06-30
- **Final completion:** 2028-06-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07634263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07634263, "Why Patients Decline or Are Being Deemed Ineligible to Receive Home-based Treatment: a Mixed Methods Study". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07634263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*